TimelyMD's $60M investment for higher ed telehealth, Vessel's $8M for in-home wellness testing and more digital health fundings

Also: Sano Genetics raises $3.2 million for genome sequencing and health research; Aavia launches Gen Z hormone health brand with $2.5 million seed funding.
By MobiHealthNews
02:49 pm

TimelyMD, a telehealth provider targeting college and university customers, has picked up a $60 million investment from JMI equity.

The company acts as an extension of a school's existing student health facilities, offering round-the-clock medical, mental health, psychiatry and health-coaching virtual visits. The company said that it has a presence on 80 campuses, and is now available to 10 times as many students as it was in early 2020.

With the latest investment, the company said that it will grow its team, enhance students' user experiences and improve health literacy at its partner institutions.

“This investment from JMI enables TimelyMD to achieve our vision to empower students to be well and thrive, eliminate barriers to care for an exponentially greater number of students, and better serve a growing and diverse range of institutions,” Luke Heji, CEO and cofounder of TimelyMD, said in a statement. 

In-home wellness testing startup Vessel has announced an $8 million raise, which the company said brings its total seed funding to $14.5 million. Monogram Capital Partners led the raise, which also saw participation from Able, BFG, Cove, Sidekick and individual investors.

The company sells testing cards for use in the home. After urinating on the testing strip, users can review their results within 10 minutes on the company's app. The wellness cards cover a handful of different metrics such as calcium, pH, creatinine and vitamins. They are available as recurring membership offerings for daily, weekly and monthly testing.

The company launched its product in November, and said that it has so far sold more than 100,000 testing cards. It did not outline how the new funds would be used.

"Vessel's technology enables people to assess their health and wellbeing from the comfort of their own homes at a time when the focus on wellness optimization has never been more prescient," Jared Stein, cofounder and partner of Monogram Capital, said in a statement.

"We are strong believers in the shift toward at-home diagnostics as the next wave of innovation enabling consumers to assess and optimize their personalized nutrition needs on a far more real-time basis than the traditional annual doctor's checkup."

Sano Genetics, a startup that offers free home genome sequencing and data reports that customers can choose to include in health research, has raised $3.2 million (£2.5 million) in a seed funding round led by Episode1 Ventures. Seedcamp, Cambridge Enterprise, January Ventures and a handful of unnamed angel investors also participated.

Founded in 2017, the company built its digital platform on the back of $687,000 (£500,000) in pre-seed funding. Per the announcement, Sano wants to expand its platform and build on its prior research projects into multiple sclerosis, ulcerative colitis and other conditions by launching a new Parkinson's disease project later this year.

In addition, the funding and a separate Innovate U.K. grant will be supporting 3,000 home DNA kits for another Sano project focused on patients experiencing "long COVID."

“This tranche of funding will help us further develop the end-to-end experience for the many people keen to contribute to personalized medical research, including clinical trials of potentially life-changing medicines and, in doing so, improve the outlook for people living with chronic and often debilitating conditions,” Charlotte Guzzo, COO of Sano, said in a statement.

Brooklyn-based Aavia has launched its digital hormone health brand on the back of $2.5 million in seed funding, Forbes reports.

The brand targets the Generation Z demographic with a free and premium ($8 per month) app that helps track users' periods, moods, symptoms and more while providing hormone health-education content and a user community. In addition, the app connects to a $79 smart birth-control case, which tracks when a pill is taken and triggers adherence reminders.

Outside of the launch, the company did not outline specific plans for the funding.

Digital health company Kevala landed $4 million in seed funding this week. Vulcan Capital, Costanoa Ventures, High Alpha and PSL Ventures all participated in this round.

The platform is centered on senior care, specifically at long-term care facilities. Its platform helps staff onboard, schedule visits and provide educational material. The company also works on centralizing records and compliance materials. According to a GeekWire article, the company plans to use the new funds to grow its team, which currently has five members.


The latest news in digital health delivered daily to your inbox.

Thank you for subscribing!
Error! Something went wrong!